A new survey by Johnson & Johnson (J&J) MedTech reveals that Europeans are generally willing to share their healthcare data in exchange for personalised treatment plans. In Europe, based on responses from France, Germany, Italy, and the UK, 73% said they supported data sharing for personalised treatment plans. Additionally, 76% would ‘feel excited’ about the future of healthcare if technology produced data that made medical and surgical training easier, while 65% reported being ‘excited’ about the use of AI in healthcare. Among healthcare professionals (HCPs), this figure rose to 86%. The online survey featured responses from 11,412 adults in the general population and 964 HCPs across 11 countries, including the UK, US, Italy, and Japan. J&J asserted that the survey results indicated that people “trust technology for key aspects of their healthcare and believe it will continue to deliver benefits”. Other HCP-specific analyses of the survey responses found that 89% of European HCPs agreed that data and technology would significantly support personalised treatment plans, with 92% convinced technology enhances precision in surgical procedures, and 90% agreeing that it may improve overall workflow and decision-making within healthcare systems. J&J MedTech said it conducted the survey as part of efforts to integrate technologies that enhance patient outcomes and tackle key healthcare challenges. The medtech giant is working on innovations such as the use of AI-driven tools for analysing patient data ahead of surgery, cardio mapping systems that provide real-time insights to support clinical decisions, and surgical solutions that personalise procedures such as total knee arthroplasty. To fully realise the potential of these technologies at scale, greater connectivity of data across clinical and operational systems will be essential, it added. Dr Julia Fishman, head of digital solutions for the EMEA region at J&J MedTech, commented: "With our longstanding commitment to support patients and providers across Europe, we champion the transformative potential of data and technology in healthcare. "As patients and healthcare professionals express a clear appetite for data-driven care, we have a collective responsibility - across industry, policymakers and healthcare systems - to unlock the potential of technology safely and meaningfully." "J&J Medtech survey finds strong European support for healthcare data sharing" was originally created and published by Medical Device Network, a GlobalData owned brand. Story Continues The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
J&J Medtech survey finds strong European support for healthcare data sharing
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...